Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

ProPhase Labs (PRPH) 10K Form and Latest SEC Filings 2026

ProPhase Labs logo
$0.10 0.00 (-4.21%)
As of 02:20 PM Eastern

Latest ProPhase Labs SEC Filings & Recent Activity

ProPhase Labs (NASDAQ:PRPH) has submitted 270+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form NT 10-K submitted on March 27, 2026.

10-Q
ProPhase Labs Files Quarterly Report on Nov. 19, 2025

The 10-Q contains ProPhase Labs's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

ProPhase Labs SEC Filing History

Browse ProPhase Labs' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
03/27/2026 4:10 PM
ProPhase Labs (868278) Filer
Form NT 10-K
01/27/2026 10:06 AM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2026 4:15 PM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2026 4:20 PM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2026 3:23 PM
Nasdaq Stock Market LLC (1354457) Filed by
ProPhase Labs (868278) Subject
Form 25-NSE
01/09/2026 4:15 PM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2026 4:10 PM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2026 4:10 PM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2025 4:04 PM
ProPhase Labs (868278) Filer
Form 424B5
12/19/2025 2:37 PM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2025 12:03 PM
ProPhase Labs (868278) Filer
Form 424B5
12/19/2025 12:07 PM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2025 12:30 PM
ProPhase Labs (868278) Filer
Form 8-K/A
12/12/2025 10:41 AM
ProPhase Labs (868278) Filer
Form 8-K/A
11/26/2025 1:15 PM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2025 3:06 PM
ProPhase Labs (868278) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/19/2025 8:00 AM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/10/2025 8:55 PM
Abenante Carolina (1965925) Reporting
ProPhase Labs (868278) Issuer
Form 3
Initial statement of beneficial ownership of securities  
10/31/2025 4:38 PM
ProPhase Labs (868278) Filer
Form DEF 14A
10/21/2025 4:29 PM
ProPhase Labs (868278) Filer
Form S-1
Registration statement under Securities Act of 1933  
10/21/2025 3:49 PM
ProPhase Labs (868278) Filer
Form PRE 14A
10/15/2025 4:22 PM
ProPhase Labs (868278) Filer
Form 424B5
10/15/2025 1:15 PM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2025 9:20 AM
ProPhase Labs (868278) Filer
Form 424B3
10/06/2025 5:05 AM
ProPhase Labs (868278) Filer
Form 424B3
09/15/2025 8:16 AM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2025 3:05 PM
Karkus Ted William (1457896) Reporting
ProPhase Labs (868278) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2025 5:15 AM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2025 7:00 AM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2025 7:01 AM
ProPhase Labs (868278) Filer
Form DEFA14A
08/15/2025 4:08 PM
ProPhase Labs (868278) Filer
Form DEF 14A
08/13/2025 4:07 PM
ProPhase Labs (868278) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2025 8:00 AM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2025 7:00 AM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2025 4:17 PM
ProPhase Labs (868278) Filer
Form PRE 14A
07/28/2025 7:20 AM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2025 6:15 PM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2025 7:00 AM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2025 7:00 AM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2025 8:04 AM
ProPhase Labs (868278) Filer
Form D
Notice of Exempt Offering of Securities 
07/01/2025 8:00 AM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
06/27/2025 8:00 AM
ProPhase Labs (868278) Filer
Form 8-K/A
06/26/2025 4:25 PM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025 4:14 PM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2025 4:07 PM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025 8:00 AM
ProPhase Labs (868278) Filer
Form DEF 14A
05/20/2025 7:00 AM
ProPhase Labs (868278) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

ProPhase Labs SEC Filings - Frequently Asked Questions

ProPhase Labs (PRPH) has submitted 270+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

ProPhase Labs's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form NT 10-K submitted on March 27, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:PRPH) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners